VivianAndrewFonsecaMD

Endocrinology • New Orleans, LA

Diabetes, Lipid Metabolism

Professor of Medicine, Tulane University

Join to view full profile

Dr. Fonseca is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Fonseca's full profile

Already have an account?

Office
1415 Tulane Ave
# TW24
New Orleans, LA 70112
Phone+1 504-988-5030

Fax+1 504-582-7973
Is this information wrong?

Education & Training

Tulane University School of MedicineClass of 1974

Certifications & Licensure

LA State Medical License 1998 - 2024
AR State Medical License 1993 - 2022
NY State Medical License 1993 - 2018
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Super Doctor SuperDoctors.com
Fellow (FACE) American Association of Clinical Endocrinology
Join now to see all

Clinical Trials

Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D) Start of enrollment: 2006 Oct 01
Completed
Phase 2, Phase 3
Comparison of Insulins Aspart and Lispro in Insulin Pumps Start of enrollment: 2004 Oct 01
Completed
Phase 4
Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN) Start of enrollment: 2008 Jun 01
Completed
Phase 4
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II Start of enrollment: 2008 Nov 01
Completed
Phase 2, Phase 3
Effect of Continuous GHRP-3 Infusion at on GH-IGF-I System, Blood Pressure, Glucose, and Insulin Resistance Start of enrollment: 2008 Jul 01
Withdrawn
Phase 1, Phase 2
An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes Start of enrollment: 2009 Aug 01
Completed
Phase 3
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM) Start of enrollment: 2010 Jan 01
Completed
Phase 4
Diabetes Remote Care Management System Start of enrollment: 2011 May 01
Completed
Not Applicable
Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese Start of enrollment: 2012 Dec 01
Terminated
Not Applicable
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
Completed
Phase 3
Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM) Start of enrollment: 2014 Dec 01
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

Degree of joint risk factor control and hazard of mortality in diabetes patients: a matched cohort study in UK Biobank.
Jian Zhou, Xuan Wang, Rui Tang, Minghao Kou, Hao Ma, Xiang Li, Yoriko Heianza, Vivian Fonseca, Lu Qi> ;BMC Medicine. 2024 Mar 7
Effects of Non-Face-to-Face Chronic Care Management on Service Utilization and Outcomes Among US Medicare Beneficiaries with Diabetes.
Hong, D., Stoecker, C., Shao, Y., Nauman, E., Hu, G., Bazzano, A., Kabagambe, E., Shi, L., Fonseca, V.> ;Journal of General Internal Medicine. 2024 Feb 21
Risk factor control and incident cardiovascular disease in patients with diabetes: Sex-specific relations.
Wang, X., Ma, H., Li, X., Liang, Z., Qi, L., Fonseca, V.> ;Diabetes, Obesity & Metabolism. 2024 Apr 1
5-Year simulation of diabetes-related complications in people treated with tirzepatide or semaglutide versus insulin glargine.
Shu Niu, Khalid A Alkhuzam, Dawei Guan, Tianze Jiao, Lizheng Shi, Vivian Fonseca, Neda Laiteerapong, Mohammed K Ali, Desmond A Schatz, Jingchuan Guo, Hui Shao> ;Diabetes, Obesity & Metabolism. 2024 Feb 1
Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine.
Cyrus V Desouza, Julio Rosenstock, Takuji Kohzuma, Vivian A Fonseca> ;The Journal of Clinical Endocrinology and Metabolism. 2023 Oct 18
Ethnic disparities of vascular complications in pre-diabetes, undiagnosed diabetes, and newly diagnosed diabetes.
Yilin Yoshida, Yuanhao Zu, Vivian A Fonseca> ;Primary Care Diabetes. 2023 Dec 1
Dietary intake during a pragmatic cluster-randomized weight loss trial in an underserved population in primary care.
John W Apolzan, Corby K Martin, Robert L Newton Jr, Candice A Myers, Connie L Arnold, Terry C Davis, William D Johnson, Dachuan Zhang, Christoph Höchsmann, Vivian A Fo...> ;Nutrition Journal. 2023 Aug 2
Sex differences in cardiometabolic biomarkers during the pre-diabetes stage.
Yilin Yoshida, Zhipeng Chen, Vivian A Fonseca, Franck Mauvais-Jarvis> ;Diabetes Research and Clinical Practice. 2023 Sep 1
External Validation of the BRAVO Diabetes Model Using the EXSCEL Clinical Trial Data.
Yixue Shao, Hui Shao, Vivian Fonseca, Lizheng Shi> ;Diabetes Therapy. 2023 Sep 1
14 citations
Joint association of loneliness and traditional risk factor control and incident cardiovascular disease in diabetes patients.
Xuan Wang, Hao Ma, Xiang Li, Yoriko Heianza, Vivian Fonseca, Lu Qi> ;European Heart Journal. 2023 Jul 21
Sex Differences in Cardiovascular Risk Associated With Prediabetes and Undiagnosed Diabetes.
Yilin Yoshida, Zhipeng Chen, Vivian A Fonseca, Franck Mauvais-Jarvis> ;American Journal of Preventive Medicine. 2023 Nov 1
1 citations
Pax4 in Health and Diabetes.
Jenna Ko, Vivian A Fonseca, Hongju Wu> ;International Journal of Molecular Sciences. 2023 May 5
Sex differences in prognostic role of fasting glucose, Oral glucose tolerance, and HbA1c in diabetic cardiovascular disease.
Yilin Yoshida, Zhipeng Chen, Robin L Baudier, Marie Krousel-Wood, Amanda H Anderson, Vivian A Fonseca, Franck Mauvais-Jarvis> ;Journal of Diabetes. 2023 Feb 1
3 citations
The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Comprehensive Metabolic Biomarkers Among Multimorbid Patients With Type 2 Diabetes.
Yixue Shao, Charles Stoecker, Dongzhe Hong, Elizabeth Nauman, Vivian Fonseca, Gang Hu, Alessandra N Bazzano, Daniel Fort, Edmond K Kabagambe, Lizheng Shi> ;Medical Care. 2023 Mar 1
5 citations
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases.
Yehuda Handelsman, Javed Butler, George L Bakris, Ralph A DeFronzo, Gregg C Fonarow, Jennifer B Green, George Grunberger, James L Januzzi Jr, Samuel Klein, Pamela R Ku...> ;Journal of Diabetes and Its Complications. 2023 Feb 1
1 citations
Rising Prediabetes, Undiagnosed Diabetes, and Risk Factors in Young Women.
Yilin Yoshida, Jia Wang, Yuanhao Zu, Vivian A Fonseca, Franck Mauvais-Jarvis> ;American Journal of Preventive Medicine. 2023 Mar 1
6 citations
Using modern risk engines and machine learning/artificial intelligence to predict diabetes complications: A focus on the BRAVO model.
Hui Shao, Lizheng Shi, Yilu Lin, Vivian Fonseca> ;Journal of Diabetes and Its Complications. 2022 Nov 1
5 citations
The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Health Utilization Among Patients With Type 2 Diabetes in Louisiana.
Yixue Shao, Charles Stoecker, Dongzhe Hong, Elizabeth Nauman, Vivian Fonseca, Gang Hu, Alessandra N Bazzano, Edmond K Kabagambe, Lizheng Shi> ;Value in Health. 2023 May 1
4 citations
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use.
Peter Rossing, Rajiv Agarwal, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Luis M Ruilope, Vivian Fonseca, Guillermo E Umpierrez, Maria Luiza Caramori, Amer Jos...> ;Diabetes, Obesity & Metabolism. 2023 Feb 1
4 citations
Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in People with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the US.
Hui Shao, Abdul Jabbar Omar Alsaleh, Terry Dex, Elisheva Lew, Vivian Fonseca> ;Diabetes Therapy. 2022 Sep 1
10 citations
Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes - A systematic review and meta-analysis.
Yilin Yoshida, Preeti Joshi, Saba Barri, Jia Wang, Amy L Corder, Samantha S O'Connell, Vivian A Fonseca> ;Journal of Diabetes and Its Complications. 2022 Aug 1
2 citations
The Joint Secular Trends of Sleep Quality and Diabetes Among US Adults, 2005-2018.
Xuan Wang, Hao Ma, Shaveta Gupta, Yoriko Heianza, Vivian Fonseca, Lu Qi> ;The Journal of Clinical Endocrinology and Metabolism. 2022 Nov 23
15 citations
Sex Differences in the Progression of Metabolic Risk Factors in Diabetes Development.
Yilin Yoshida, Zhipeng Chen, Robin L Baudier, Marie Krousel-Wood, Amanda H Anderson, Vivian A Fonseca, Franck Mauvais-Jarvis> ;JAMA Network Open. 2022 Jul 1
Changes in body size phenotypes from childhood to adulthood and the associated cardiometabolic outcomes.
Tingting Du, Vivian Fonseca, Wei Chen, Lydia A Bazzano> ;Diabetes Research and Clinical Practice. 2022 May 1
11 citations
Potential Gains in Life Expectancy Associated With Achieving Treatment Goals in US Adults With Type 2 Diabetes.
Hamed Kianmehr, Ping Zhang, Jing Luo, Jingchuan Guo, Meda E Pavkov, Kai McKeever Bullard, Edward W Gregg, Naykky Singh Ospina, Vivian Fonseca, Lizheng Shi, Hui Shao> ;JAMA Network Open. 2022 Apr 1
Join now to see all

Journal Articles

Weight Loss in Underserved Patients — A Cluster-Randomized Trial
Eboni G Price-Haywood, Tina K Thethi, Vivian Fonseca, Jonathan Gugel, Benjamin Springgate, New England Journal of Medicine
Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes
Vivian Fonseca, David M Nathan, Jonathan Newman, The Journal of Clinical Endocrinology and Metabolism
GLP-1 Receptor in Pancreatic Α Cells Regulates Glucagon Secretion in a Glucose-Dependent Bidirectional Manner
Weiwei Xu, Vivian A Fonseca, Diabetes Care

Lectures

The Intersection of Heart Failure and Diabetes
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
A Model‐Based Meta‐Analysis of 24 Antihyperglycemic Drugs for Type 2 Diabetes: Comparison of Treatment Effects at Therapeutic Doses
New Orleans, LA - 6/15/2014
A Model‐Based Meta‐Analysis of 24 Antihyperglycemic Drugs for Type 2 Diabetes: Comparison of Treatment Effects at Therapeutic Doses
Vivian Fonseca, MD - 6/13/2014

Press Mentions

Ozempic Shortage: How a Weight Loss Fad Has Slashed Access to a Diabetes DrugOctober 28th, 2022
Fractyl Health Provides Initial Clinical Update on Open-Label REVITA-T2DiJanuary 18th, 2022
Fractyl Announces Tenth Trial Site Opened in REVITA-T2Di Study of Revita® DMR for Type 2 DiabetesSeptember 1st, 2021
Join now to see all

Committees

member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY
member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2026

Hospital Affiliations

Tulane-Lakeside HospitalMetairie, Louisiana
Tulane Medical CenterNew Orleans, Louisiana
Veterans Affairs HospitalNew Orleans, Louisiana
University Medical CenterNew Orleans, Louisiana